Refractory cryptococcal meningoencephalitis in a patient with multiple sclerosis treated with fingolimod: A case report

201715 citationsJournal Articlegold Open Access

Authors

Tony Anene-Maidoh · Virginia Commonwealth University

Robert M. Paschall · Shore Memorial Hospital

R. Scott Graham · Virginia Commonwealth University

Abstract

• Fingolimod is used to treat relapsing-remitting multiple sclerosis (RRMS). • Fingolimod was the 1st orally administered disease modifier approved for RRMS. • We report a case of cryptococcal meningoencephalitis in a patient on fingolimod. • Awareness of the risk of fatal opportunistic infections in patients on fingolimod

Topics & Keywords

Fungal Infections and Studies Antifungal resistance and susceptibility Plant-Microbe Interactions and Immunity

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Interdisciplinary Neurosurgery

Volume 12, pp. 8-9

DOI: 10.1016/j.inat.2017.10.005

Field-Weighted Citation Impact: 1.21